A decision support system called GI TARGET may help integrate precision medicine into routine care for patients with gastrointestinal cancer, according to researchers.
An intervention can increase serious illness conversations and reduce the use of systemic therapy at the end of life in patients with cancer.
US medical oncologists may lack understanding of biosimilars and have limited access to education about these products, a survey suggests.
Using telehealth saved cancer patients an estimated $147.40 to $186.10 per visit, as well as 1.2 hours of in-clinic time and 2.9 hours of roundtrip driving time.
Some patients do not understand common phrases oncologists use, such as “your tumor is progressing” or “your nodes are positive.”
The use of oncology hospitalists can reduce readmission rates and improve discharge to hospice, a study suggests.
Medicare’s Oncology Care Model (OCM) did not deter oncologists from prescribing more expensive novel cancer therapies.
The change from 2018 to 2022 could mean 14.8% more penalties and 42.8% fewer bonuses for oncologists.
A team of investigators examined the financial burden of breast, lung, colorectal, and prostate cancers for nonelderly adults with private insurance.
In a cohort of privately-insured patients, the median out-of-pocket cost for genetic counseling was $0.
From 2010 to 2019, the percentage of oncology practices with medically integrated dispensing more than doubled.
Prompt postdischarge follow-up was associated with decreased likelihood of ED visits and readmissions at 30 days in patients with cancer.
Experts provide consensus-based guidance for managing advanced cancer-related pain in patients with opioid use disorder or opioid misuse.
Some disparities that existed before FDA approval persisted after approval, and some new disparities emerged after FDA approval.
Vitamin E does not decrease the risk of cancer or cancer-related death, and the risk of harm from beta carotene outweighs any potential benefits, according to the USPSTF.
A point-of-care program increased the proportion of cancer patients who stopped smoking from 12% to 17.2%.
The shortage is expected to last until at least June 30, according to the American Hospital Association.
The remote monitoring intervention reduced the rate of grade 3 or higher adverse events and the length of hospital stays.
The use of proton beam therapy (PBT) increased between 2004 and 2018, particularly for cancers in which the effectiveness of PBT is still under investigation.
The median price markup was as high as 633.6% for 1 drug.